N

NovaBridge Biosciences
D

NBP

3.49500
USD
-0.14
(-3.72%)
مغلق
حجم التداول
40,966
الربح لكل سهم
-0
العائد الربحي
-
P/E
-11
حجم السوق
402,942,157
أصول ذات صلة المقالات

العنوان: NovaBridge Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.